Find a Doctor

Xin G. Cao

Nanjing Medical University


Xin Cao is in Nanjing, China. They have been an author on 154 peer reviewed articles in the past 15 years.


Nanjing, 21116, CN

Latest Research

Latest Advance
  • Condition: Risk of Bone Fracture in Patients with Type 2 Diabetes
  • Journal: Diabetes/metabolism research and reviews
  • Treatment Used: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs)
  • Number of Patients: 39795
  • Published —
This study evaluated the association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and the risk of bone fracture in patients with type 2 diabetes mellitus (T2DM).

Clinical Trials

This doctor has not participated in any recent clinical trials.


Nanjing, 21116, CN


Contact them to find out if they accept your insurance plan.